Egyptian International Pharmaceutical Industries Company

E£104.10As of Sun 8 Nov 2026, 12:00 UTC
EGX:PHARHealthcare
Country Egypt
PE (Fwd) •••
TSR 10Y CAGR 15.25%
Div yield 1.44%
ROE 20.51%
Pharmaceutical Preparations
Beta (5Y) 0.59
PE TTM 13.61
TSR TTM 37.43%
Mkt cap E£17.57B
ROIC 11.31%
SE Grade™
Value
Quality
Moat
Consensus
Reference
E£119
14.36%
(85.58%)
Hold 10|11|2|10|7
4Q25
1Q26
2Q26
3Q26
Earnings per shareE£
1.10
1.07
1.10
1.06
7.76%
3.43%
4.49%
5.50%
RevenueE£B
1.072
1.133
1.200
1.251
14.49%
14.92%
16.36%
17.39%
Peers (US$321.4M)
Cap (US$)
PE
489.7M
135.9x
370.3M
—
Capital
TTM
5Y
10Y
Leveragex
1.097
(0.609)
(0.519)
EBIT/Intx
0.070
0.294
0.317
Own earn%
390.74
(92.44)
(102.29)
Sh yield%
32.93
31.52
30.32
Owners
Insiders/Inst%
10.68
78.10
Short interest%
4.96
SBC / revenue%
4.12
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
23–34
$1 testx
0.0
Incr. ROIC%
2